Font Size: a A A

Metabolic Tumor Burden From18F-FDG PET/CT Images As An Independent Prognostic Factor In Post-surgical Males With Squamous Esophageal Cancer

Posted on:2014-02-12Degree:MasterType:Thesis
Country:ChinaCandidate:H YuanFull Text:PDF
GTID:2254330422964219Subject:Medical imaging and nuclear medicine
Abstract/Summary:PDF Full Text Request
Objective To determine an optimal threshold method for the segmentation of metastaticlesions from18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computertomography (PET/CT) images, and evaluate18F-FDG PET/CT metabolic tumor burden withthis threshold as a post-surgical predictor of prognosis in males with esophageal squamouscell carcinoma.Methods18F-FDG PET/CT scanning was performed for post-surgical evaluation of34patients with esophageal squamous cell carcinoma, with each visible lesion delineated bythree thresholds, Thbgd20,Th40and Th2.5, using3D-area growing algorithms. The numbers oflesions in each patient successfully segmented by the three thresholds were compared, withwhole body total lesion glycolysis (WBTLG) calculated as the total lesion glycolysis (TLG)of all lesions. Risk factors for death were determined by multivariate regression analysis, andtime dependent receiver operating characteristic curves were used to determine the optimalWBTLG threshold predictive of death.Results The34patients had a total of120lesions confirmed by long-term clinical follow-upor pathological findings, of which118(98.3.0%),96(80.0%) and98(81.7%) could bedelineated by the Thbgd20,Th40and Th2.5thresholds, respectively. Thbgd20delineatedsignificantly more lesions than Th40and Th2.5(P<0.001) while Th2.5did not statisticallydelineated more lesions then Th40did (P=0.717). The optimal WBTLG cutoffs predictingpatient prognoses for1,2year,3years above were33.96,13.42, and13.42, respectively.The area under the curve predicting survival for1,2,3years and above were0.87,0.89,0.96, and0.96,respectively. Multivariate regression analysis showed that WBTLG (relativerisk [RR]1.005;95%confidence interval [CI]1.003-1.007, P<0.001) and post-surgical Tstaging (RR2.295;95%CI1.049-5.020, P=0.037) were significant predictors of survival, whereas age, post-surgical N and M stages, and F-18-FDG PET/CT based T, N and M stagesand number of lesions were not.Conclusion Whole body metabolic tumor burden using the Thbgdthreshold is a promisinglong-term independent prognostic factor in the post-surgical evaluation of males withesophageal squamous cell carcinoma.
Keywords/Search Tags:Positron emission tomography, Esophageal squamous carcinoma, Metabolictumor burden, Total lesion glycolysis, Prognostic factor
PDF Full Text Request
Related items
Using18F-FDG PET/CT To Estimate The Length Of Primary Tumor And The Short-term Outcome To Chemoradiation Of Esophageal Squamous Cell Carcinoma Patients
A Clinical Study On Feasibility Of18F-FDG PET-CT Guided Simultaneous Integrated Boost-radiation Therapy In Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Responsive Prediction Of Radiotherapy For Esophageal Squamous Cell Carcinoma With Compositive Indexes
The Predictive Value Of Metabolic Parameters From 18F-FDG PET/CT Imaging In The Prognosis Of Esophageal Squamous Cell Carcinoma After Non-operation Therapy
Impact Of18F-FDG PET/CT Before Radiotherapy On Treatment Regimen And Prognostic Significance Of PET/CT Parameters In Patients With Esophageal Cancer
Baseline 18F-FDG PET/CT Radiomics Combined Clinical And Dissemination Features Could Predict Interim Respons And Prognosis In DLBCL
Progress Of Pretreatment Metabolic Parameters From 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography In Predicting The Prognosis Of Esophageal Cancer Receiving Radiotherapy
Application Of PET-CT Radiomics In The Treatment Of Pathological Complete Response By Neoadjuvant Immunotherapy Combined With Chemotherapy In Patients With Esophageal Squamous Cell Carcinoma
Prognostic Value Of Metabolic Parameters Of Pretreatment 18F–FDG PET/CT In Patients With Esophageal Cancer
10 Clinical Value Of 18F-FDG PET/CT Imaging In The Recurrence And Metastasis Of Anastomotic Stomach In Patients With Esophageal Cancer